Lewis Joel
Galectin Therapeutics Inc. · President and CEO
Lewis Joel is listed in public filings as director, officer: President and CEO. This Lewis Joel insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Galectin Therapeutics Inc. (GALT). Investors use Lewis Joel's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $50k56k shares | SellDec 23, 2024 | $0.8859 | -- | |
| $89k14k shares | SellSep 12, 2025 | $6.36 | -- | |
| $7.8k1.3k shares | SellNov 3, 2025 | $6.01 | -- | |
| $88k14.4k shares | SellNov 4, 2025 | $6.07 | -- | |
| $1.2k200 shares | SellNov 5, 2025 | $6.00 | -- | |
| $11k1.9k shares | SellNov 10, 2025 | $6.03 | -- | |
| $95k15.7k shares | SellNov 17, 2025 | $6.04 | -- | |
| $42k6.8k shares | SellNov 18, 2025 | $6.15 | -- | |
| $55k7.8k shares | SellDec 17, 2025 | $7.06 | -- | |
| $108k27.7k shares | SellJan 5, 2026 | $3.91 | -- | |
| $78k18.6k shares | SellJan 2, 2026 | $4.20 | -- |